Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor X deficiency.

James Uprichard1, David J Perry

  • 1Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK.

Blood Reviews
|July 20, 2002
PubMed
Summary
This summary is machine-generated.

Factor X deficiency is a rare autosomal recessive disorder affecting blood coagulation. Treatment involves protein replacement, but caution is advised with certain concentrates due to thrombosis risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world management, resource use, patient-reported outcomes and adherence in patients receiving direct oral anticoagulants for first stroke attributed to non-valvular atrial fibrillation in secondary care: A UK mixed-methods observational study.

PloS one·2025
Same author

Impact of antithrombotic agents on outcomes in patients requiring surgery for chronic subdural haematoma: a systematic review and meta-analysis.

British journal of neurosurgery·2024
Same author

Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma.

Wellcome open research·2024
Same author

Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study.

Critical care (London, England)·2023
Same author

Rare case of hepatocellular carcinoma metastasising to the pituitary and cavernous sinus causing panhypopituitarism and bilateral ophthalmoplegia.

BMJ case reports·2020
Same author

A single-centre review of iatrogenic anaemia in adult intensive care.

Transfusion medicine (Oxford, England)·2020
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Hematology

Background:

  • Factor X is a vitamin K-dependent serine protease essential for blood clot formation.
  • It initiates the common pathway of the coagulation cascade.
  • Factor X gene is located on chromosome 13, showing homology to other vitamin K-dependent factors.

Purpose of the Study:

  • To summarize the role of Factor X in coagulation.
  • To describe the genetic basis and inheritance of Factor X deficiency.
  • To outline the clinical presentation and management of Factor X deficiency.

Main Methods:

  • Literature review of Factor X function, genetics, and deficiency.
  • Analysis of gene structure and protein homology.
  • Review of clinical phenotypes and treatment strategies.

Related Experiment Videos

Main Results:

  • Factor X deficiency is a rare inherited coagulation disorder with autosomal recessive inheritance.
  • Clinical presentation varies, with homozygous deficiency incidence at 1:1,000,000.
  • Acquired deficiency is rare, often linked to amyloidosis.

Conclusions:

  • Factor X is vital for hemostasis, and its deficiency presents with bleeding tendencies.
  • Management requires careful consideration of replacement therapies to mitigate thrombosis risks.